Cancer care is becoming more complicated, creating a larger gap between specialty hospitals and local physicians, The Wall Street Journal reported Oct. 22.

The territory of Puerto Rico had the lowest colorectal cancer screening rate in 2022 at 55.5% — nearly 20 percentage points lower than the state with the highest rate of 75.3%, Connecticut.

Salt Lake City-based Intermountain Health has opened a new cancer center at the system's Holy Rosary Hospital in Miles City, Mont.

Timothy Mullett, MD, leaned toward his computer screen as he spoke, drowning out the sounds of the busy coffee shop behind him to get his message across. 

Norman-based University of Oklahoma has received a $17.2 million grant from the National Institutes of Health to improve cancer outcomes in Native American tribal nations and communities. 

Cancer care designations serve as a way to distinguish the research, clinical services, and cancer prevention efforts taking place at a cancer center, hospital or health system. 

The American Cancer Society has named Wayne Frederick, MD, as interim CEO of the organization and its advocacy affiliate, the American Cancer Society Cancer Action Network. The news comes one month after the organization announced its current CEO, Karen Knudsen, PhD, was planning her exit.

Towson, Md.-based Greater Baltimore Medical Center has finished construction on a new $94 million cancer center where it will begin seeing patients early next year, according to an Oct. 16 report from the Baltimore Business Journal. 

Philadelphia-based Fox Chase Cancer Center has been named a Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine & Molecular Imaging. Fox Chase is the first center in Philadelphia and one of three in Pennsylvania to receive the designation.

Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center had the lowest 30-day unplanned readmission rate of cancer hospitals exempt from reporting to Medicare's Inpatient Prospective Payment System.

The state of Wyoming had the lowest breast cancer screening rate in 2022 at 59.5% — nearly 20% lower than the state with the highest rate of 78.4%, Rhode Island.

Omaha, Neb.-based University of Nebraska Medical Center's Fred & Pamela Buffett Cancer Center has launched a new cancer prevention and control program to address cancer risk factors and population disparities specific to Nebraska. 

Effective Sept. 10, the FDA required healthcare facilities providing breast imaging services to notify patients of their breast density in mammography reports. Now, some experts are expressing concern over the new mandate, according to an Oct. 12 report from NBC News. 

The National Cancer Institute has launched a toolkit as part of its National Standards for Cancer Survivorship Care initiative to help health systems develop and improve survivorship care programs. 

Kansas City-based University of Kansas Cancer Center has launched the Center for Survivorship and Patient-Oriented Research as part of an initiative to improve not only cancer survival rates, but cancer survivor quality of life.

New York City-based NYU Langone has named Shridar Ganesan, MD, PhD, as director of the Perlmutter Cancer Center's new Center for Molecular Oncology. In collaboration with teams across NYU Langone, Dr. Ganesan will lead integration of genomic sequencing to personalize cancer care plans.

Houston-based University of Texas MD Anderson Cancer Center has partnered with the Union for International Cancer Control to address breast and cervical cancer on a global scale. 

Cancer survival among young adults has increased since the ACA's Dependent Care Expansion passed in 2010, allowing Americans to stay on their parents' health insurance plans until turning 26 years old, according to a study published Oct. 7 in Cancer. 

Los Angeles-based Cedars-Sinai is participating in the National Cancer Institute's first long-term national study of cancer among Asian Americans. Led by the University of California San Francisco, the study aims to learn why Asian Americans experience higher rates of cancer compared to other groups.

Advancements in immunotherapy and personalized medicine have pushed the oncology field forward, according to leaders from MD Anderson and City of Hope who shared their insights with Becker's.